Cargando…
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement
Objective. Systemic sclerosis (SSc) is a rare, heterogeneous disease, which affects different organs and therefore requires interdisciplinary diagnostic and therapeutic management. To improve the detection and follow-up of patients presenting with different disease manifestations, an interdisciplina...
Autores principales: | Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., Melchers, I., Meurer, M., Moinzadeh, P., Müller-Ladner, U., Pfeiffer, C., Riemekasten, G., Schulze-Lohoff, E., Sunderkoetter, C., Weber, M., Worm, M., Klaus, P., Rubbert, A., Steinbrink, K., Grundt, B., Hein, R., Scharffetter-Kochanek, K., Hinrichs, R., Walker, K., Szeimies, R.-M., Karrer, S., Müller, A., Seitz, C., Schmidt, E., Lehmann, P., Foeldvári, I., Reichenberger, F., Gross, W.L., Kuhn, A., Haust, M., Reich, K., Böhm, M., Saar, P., Fierlbeck, G., Kötter, I., Lorenz, H.-M., Blank, N., Gräfenstein, K., Juche, A., Aberer, E., Bali, G., Fiehn, C., Stadler, R., Bartels, V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2468885/ https://www.ncbi.nlm.nih.gov/pubmed/18515867 http://dx.doi.org/10.1093/rheumatology/ken179 |
Ejemplares similares
-
High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy
por: Hunzelmann, Nicolas, et al.
Publicado: (2009) -
Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features
por: Mierau, Rudolf, et al.
Publicado: (2011) -
Versorgungsrealität der stationären vasoaktiven Therapie mit Prostazyklinderivaten bei Patienten mit akralen Durchblutungsstörungen bei systemischer Sklerose in Deutschland
por: Juche, A., et al.
Publicado: (2020) -
Proteinuria in systemic sclerosis: reversal by ACE inhibition
por: Schuster, J., et al.
Publicado: (2013) -
Pharmacology and rationale for imatinib in the treatment of scleroderma
por: Moinzadeh, Pia, et al.
Publicado: (2013)